World Wires · story 29472 · unverified · 1 source(s)

Clearmind Announces Patent Publication in Japan Covering Treatment for Neurological Movement Disorder

Published patent application covers 3-MMC-based treatment of dyskinesia, including in combination with Palmitoylethanolamide (PEA)

Open in the desk

Coverage

• Clearmind Announces Patent Publication in Japan Covering Treatment for Neurological Movement Disorder GlobeNewswire: public companies · tier D · clear net · 2026-10-08 11:32 UTC

What this site indexes